Long term outcomes with emicizumab in hemophilia A without inhibitors result from HAVEN 3 and 4 studies
dc.article.end-page | 12 | en |
dc.article.start-page | 1 | en |
dc.citation.doi | 10.1016/J.RPTH.2024.102364 | en |
dc.contributor.author | Johnny Mahlangu | en |
dc.contributor.author | Víctor Jimenez-Yuste | en |
dc.contributor.author | Giuliana Ventriglia | en |
dc.contributor.author | Markus Niggli | en |
dc.contributor.author | Simona Barlera | en |
dc.contributor.author | E et al | en |
dc.date.accessioned | 2024-10-18T20:48:33Z | |
dc.date.available | 2024-10-18T20:48:33Z | |
dc.faculty | FACULTY OF HEALTH SCIENCES | en |
dc.identifier.citation | WOS | en |
dc.identifier.issn | 2475-0379 | en |
dc.identifier.uri | https://hdl.handle.net/10539/41703 | |
dc.journal.title | Long term outcomes with emicizumab in hemophilia A without inhibitors result from HAVEN 3 and 4 studies | en |
dc.journal.volume | 8 | en |
dc.publisher | WILEY-BLACKWELL | en |
dc.title | Long term outcomes with emicizumab in hemophilia A without inhibitors result from HAVEN 3 and 4 studies | en |
dc.type | Journal Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Journal Article.pdf
- Size:
- 2 MB
- Format:
- Adobe Portable Document Format
- Description:
- Bitstream uploaded by REST Client